IGNE OTC
Igene Biotechnology, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -90.0%
5Y: -95.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$4M
-48.2% ▼
5Y CAGR: +2.5%
Gross Profit
$1M
-18.7% ▼
5Y CAGR: +25.7%
Operating Income
-$1M
+51.1% ▲
Net Income
-$141K
+96.5% ▲
EPS (Diluted)
$-0.00
+99.5% ▲
EBITDA
-$851K
+59.1% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2003 | FY2006 | FY2007 | FY2008 | FY2009 |
|---|---|---|---|---|---|
| Revenue | $463K | $0 | $2M | $8M | $4M |
| YoY Growth | -86.7% | +0.0% | +0.0% | +234.3% | -48.2% |
| Cost of Revenue | $446K | $0 | $2M | $6M | $3M |
| Gross Profit | $17K | $0 | $605K | $1M | $1M |
| Gross Margin | 3.7% | — | 26.5% | 16.3% | 25.7% |
| R&D Expenses | $745K | $848K | $984K | $2M | $2M |
| SG&A Expenses | $1M | $1M | $1M | $2M | $1M |
| Operating Expenses | $642K | $307K | $538K | $3M | $991K |
| Operating Income | -$625K | -$417K | $238K | -$2M | -$1M |
| Operating Margin | -134.8% | — | 10.4% | -28.6% | -27.0% |
| Interest Expense | $898K | $754K | $2M | $2M | $98K |
| Income Before Tax | -$420K | -$402K | $262K | -$2M | -$43K |
| Tax Expense | $660K | $848K | $2M | $2M | $165K |
| Net Income | -$2M | -$1M | -$2M | -$4M | -$141K |
| Net Margin | -474.5% | — | -83.0% | -52.2% | -3.6% |
| EPS (Diluted) | $-0.02 | $-0.01 | $-0.02 | $-0.02 | $-0.00 |
| EBITDA | -$541K | -$308K | $325K | -$2M | -$851K |
| Shares Outstanding | 90M | 108M | 110M | 187M | 1.54B |